ArticleScientific reports2024

A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP).

Cristian C Serrano-Mayorga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.